Fidelity Investments
ANTH

Fidelity Investments’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Fidelity Investments’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-229,586
Closed -$1.19M – 2744
2016
Q4 		$1.19M Sell
229,586
-197,015
-46% -$3.41M ﹤0.01% 2450
2016
Q3 		$10.8M Buy
426,601
+20,613
+5% +$520K ﹤0.01% 1956
2016
Q2 		$10M Buy
405,988
+61,262
+18% +$1.73M ﹤0.01% 1965
2016
Q1 		$9.98M Buy
344,726
+21,513
+7% +$584K ﹤0.01% 1964
2015
Q4 		$12M Buy
323,213
+63,450
+24% +$2.8M ﹤0.01% 1915
2015
Q3 		$12.7M Buy
+259,763
New +$18.1M ﹤0.01% 1850

Other funds holding ANTH

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments's ANTH Position: Q1 2017 in Review

Fidelity Investments sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2017, closing a stake of 229,586 shares — an estimated $1.19M sold.

Fidelity Investments first reported a position in ANTH in Q3 2015 and held it in 6 quarters. The position peaked at $12.7M in Q3 2015. 60 funds tracked by Wall St. Rank hold ANTH as of Q1 2017.

  • Fidelity Investments reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Fidelity Investments sold 229,586 Anthera Pharmaceuticals, Inc. shares in Q1 2017, an estimated $1.19M.
  • Fidelity Investments first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2015 and held it in 6 quarters.
  • Fidelity Investments's Anthera Pharmaceuticals, Inc. position peaked at $12.7M in Q3 2015.
  • 60 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2017.

Based on Fidelity Investments's 13F filing for Q1 2017, filed 11 May 2017.